Journal
MOLECULAR AND CELLULAR BIOLOGY
Volume 35, Issue 9, Pages 1491-1505Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.01402-14
Keywords
-
Categories
Funding
- Fondation ARC
- Fondation de France
- ANR
- INCA
- la Ligue Nationale Contre le Cancer (Equipe Labelisee LNCC)
- METOXIA (FP7-EU program)
- MOMP (FP7-EU program)
- MRT
- Canceropole PACA
- Centre A. Lacassagne
- CNRS
- INSERM
Ask authors/readers for more resources
The oxygen-limiting (hypoxic) microenvironment of tumors induces metabolic reprogramming and cell survival, but the underlying mechanisms involving mitochondria remain poorly understood. We previously demonstrated that hypoxia-inducible factor 1 mediates the hyperfusion of mitochondria by inducing Bcl-2/adenovirus E1B 19-kDa interacting protein 3 and post-translational truncation of the mitochondrial ATP transporter outer membrane voltage-dependent anion channel 1 in hypoxic cells. In addition, we showed that truncation is associated with increased resistance to drug-induced apoptosis and is indicative of increased patient chemoresistance. We now show that silencing of the tumor suppressor TP53 decreases truncation and increases drug-induced apoptosis. We also show that TP53 regulates truncation through induction of the mitochondrial protein Mieap. While we found that truncation was independent of mitophagy, we observed local microfusion between mitochondria and endolysosomes in hypoxic cells in culture and in patients' tumor tissues. Since we found that the endolysosomal asparagine endopeptidase was responsible for truncation, we propose that it is a readout of mitochondrial-endolysosomal microfusion in hypoxia. These novel findings provide the framework for a better understanding of hypoxic cell metabolism and cell survival through mitochondrial-endolysosomal microfusion regulated by hypoxia-inducible factor 1 and TP53.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available